Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Neurotox Res ; 22(1): 69-78, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22237943

ABSTRACT

Alzheimer disease (AD) is a neurodegenerative disorder characterized by the accumulation of ß amyloid (Aß) aggregates. Aß induces the inflammatory activation of glia, inducing secretion of Interleukin 1ß (IL1ß), nitric oxide (NO) and superoxide radicals. The specific receptor responsible for the induction of inflammatory activation by Aß, is still an open question. We propose that scavenger receptors (SR) participate in the activation of glia by Aß. We assessed production of NO, synthesis of IL1ß and activation of ERK, JNK and NF-κB signaling pathways by Western blot, in primary rat glial cultures exposed to SR ligands (fucoidan and Poly I), LPS + IFNγ (LI), and Aß. Poly I but not fucoidan nor fibrillar Aß increased threefold NO production by astrocytes in a time-dependent manner. Fucoidan and Poly I increased 5.5- and 3.5-fold NO production by microglia, and co-stimulation with Aß increased an additional 60% NO induced by SR ligands. Potentiation by Aß was observed later for astrocytes than for microglia. In astrocytes, co-stimulation with Aß potentiated ERK and JNK activation in response to Fucoidan and Poly I, whereas it reduced induction of JNK activation by LI and left unaffected NF-κB activation induced by LI. Levels of pro-IL1ß in astrocytes increased with Aß, SR ligands and LI, and were potentiated by co-stimulation with Aß. Our results suggest that SRs play a role on inflammatory activation, inducing production of NO and IL1ß, and show potentiation by Aß. Potentiation of the inflammatory response of Aß could be meaningful for the activation of glia observed in AD.


Subject(s)
Alzheimer Disease/metabolism , Amyloid beta-Peptides/metabolism , Astrocytes/metabolism , Inflammation/metabolism , Microglia/metabolism , Receptors, Scavenger/metabolism , Signal Transduction , Alzheimer Disease/immunology , Animals , Cells, Cultured , Interferon-gamma/pharmacology , Interleukin-1beta/metabolism , Lipopolysaccharides/pharmacology , Nitric Oxide/metabolism , Poly I/pharmacology , Polysaccharides/pharmacology , Rats , Receptors, Scavenger/agonists , Superoxides/metabolism
2.
J Enzyme Inhib ; 8(4): 261-5, 1995.
Article in English | MEDLINE | ID: mdl-7542323

ABSTRACT

Several homologous polynucleotides have been tested as inhibitors on the reactions catalyzed by avian myeloblastosis virus (AMV) reverse transcriptase, in the presence of polyribonucleotides and 2'-fluorinated polynucleotides as templates. Polynucleotides differentially inhibited the reactions catalyzed by reverse transcriptase in the presence of these synthetic templates. Polyriboadenylic acid (poly(rA), poly(2'-O-methyladenylic acid) (poly(Am)), poly(2'-fluoro-2'-deoxyadenylic acid) (poly(dAfl), polyinosinic acid (poly(rI)) and polyuridylic acid poly(rU)) inhibited the polyribonucleotide-, but not the 2'-fluorinated polynucleotide-directed reverse transcriptase activity.


Subject(s)
DNA/biosynthesis , Polydeoxyribonucleotides/metabolism , Polynucleotides/pharmacology , Polyribonucleotides/metabolism , RNA-Directed DNA Polymerase/metabolism , Avian Myeloblastosis Virus/enzymology , Dose-Response Relationship, Drug , Fluorine/pharmacology , Manganese/pharmacology , Poly A/pharmacology , Poly I/pharmacology , Poly U/pharmacology , Reverse Transcriptase Inhibitors , Templates, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL